Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KDM1A | O60341 | 3/20 | 0.54 |
| ▸ | MAOB | P27338 | 1/20 | 0.49 |
| ▸ | KDM5A | P29375 | 1/20 | 0.49 |
| ▸ | KDM1B | Q8NB78 | 1/20 | 0.49 |
| ▸ | MAPK8 | P45983 | 1/20 | 0.49 |
| ▸ | MAPK9 | P45984 | 1/20 | 0.49 |
| ▸ | MAPK10 | P53779 | 1/20 | 0.49 |
| ▸ | REN | P00797 | 9/20 | 0.47 |
| ▸ | OPRM1 | P35372 | 5/20 | 0.45 |
| ▸ | OPRK1 | P41145 | 5/20 | 0.45 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3215690 | 0.96 | MAPK8 (0.51) | KDM1AMAOBKDM5AKDM1BMAPK8 | |
| SCHEMBL30844390 | 0.96 | MAPK8 (0.54) | KDM1AMAOBKDM5AKDM1BMAPK8 | |
| SCHEMBL30658576 | 0.94 | KDM1A (0.51) | KDM1AMAOBKDM5AKDM1BMAPK8 | |
| SCHEMBL30381351 | 0.93 | KDM1A (0.57) | KDM1AMAOBKDM5AKDM1BMAPK8 | |
| SCHEMBL3865485 | 0.93 | MAPK8 (0.50) | KDM1AMAOBKDM5AKDM1BMAPK8 | |
| SCHEMBL30844339 | 0.92 | KDM1A (0.55) | KDM1AMAOBKDM5AKDM1BMAPK8 | |
| SCHEMBL30844393 | 0.92 | KDM1A (0.55) | KDM1AMAOBKDM5AKDM1BMAPK8 | |
| SCHEMBL30844374 | 0.92 | KDM1A (0.55) | KDM1AMAOBKDM5AKDM1BMAPK8 | |
| SCHEMBL30844394 | 0.92 | KDM1A (0.58) | KDM1AMAOBKDM5AKDM1BMAPK8 | |
| SCHEMBL29607893 | 0.90 | KDM1A (0.48) | KDM1AMAOBKDM5AKDM1BMAPK8 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20250312463-A1 | AUGMENTED PEPTIDE COMPOSITIONS AND METHODS | Neo7Bioscience, Inc. (US) | 2025-10-09 | — | — | US | disclosed |